Borrelli Eric, Babcock Zachary, Kogut Stephen
Program in Health Outcomes Research, College of Pharmacy, The University of Rhode Island, Kingston, RI, USA.
Rare Tumors. 2019 Jul 17;11:2036361319863498. doi: 10.1177/2036361319863498. eCollection 2019.
Malignant mesothelioma is a rare and devastating form of cancer with an increasing economic burden. We sought to describe the direct cost burden of mesothelioma to the US health system. A systematic literature review was performed to locate published estimates of the medical cost of mesothelioma. In addition, we performed an analysis of hospital discharge data from the National Inpatient Sample, Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality. We also reviewed publicly available legal settlements. We found that published estimates of the cost of medical care for mesothelioma are sparse, and differ with respect to nation, timeframe, and types of cost included. For the year 2014 in the United States, we estimated a mean cost per mesothelioma hospitalization of US$24,124 (95% confidence interval: US$20,819-US$28,983) and a total cost for hospital care of US$44,214,835. In conclusion, we found that reports describing the direct medical cost of care for mesothelioma in the United States are lacking, yet the per-patient cost of care is substantial, as evidenced by analyses of inpatient care and legal settlements.
恶性间皮瘤是一种罕见且极具破坏性的癌症,其经济负担日益加重。我们试图描述间皮瘤给美国医疗系统带来的直接成本负担。我们进行了一项系统的文献综述,以查找已发表的间皮瘤医疗成本估计值。此外,我们对医疗保健研究与质量局医疗成本和利用项目国家住院样本中的医院出院数据进行了分析。我们还审查了公开的法律和解协议。我们发现,已发表的间皮瘤医疗成本估计值很少,并且在国家、时间范围和所包含的成本类型方面存在差异。对于2014年的美国,我们估计每次间皮瘤住院的平均成本为24,124美元(95%置信区间:20,819美元至28,983美元),医院护理的总成本为44,214,835美元。总之,我们发现缺乏描述美国间皮瘤直接医疗护理成本的报告,但住院护理和法律和解协议的分析表明,每位患者的护理成本很高。